| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2022 | Dec 2021 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 19.93B | 25.39B | 25.22B | 23.43B | 26.23B | 28.96B |
| Gross Profit | 5.16B | 6.08B | 6.17B | 5.57B | 5.41B | 5.83B |
| EBITDA | 2.36B | 2.19B | 2.59B | 2.21B | 2.13B | 2.43B |
| Net Income | 1.26B | 1.23B | 1.35B | 1.10B | 909.14M | 1.54B |
Balance Sheet | ||||||
| Total Assets | 27.51B | 30.22B | 30.38B | 28.31B | 30.14B | 27.39B |
| Cash, Cash Equivalents and Short-Term Investments | 4.23B | 3.44B | 3.81B | 3.60B | 2.56B | 2.25B |
| Total Debt | 2.63B | 3.54B | 5.63B | 6.05B | 9.13B | 0.00 |
| Total Liabilities | 10.03B | 11.13B | 13.11B | 14.20B | 16.94B | 15.34B |
| Stockholders Equity | 17.45B | 19.06B | 17.24B | 14.08B | 13.18B | 12.03B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.78B | 473.00M | 4.02B | -852.13M | 940.00M |
| Operating Cash Flow | 0.00 | 2.11B | 981.28M | 4.50B | 47.48M | 1.49B |
| Investing Cash Flow | 0.00 | -127.90M | -203.10M | -131.05M | -801.27M | -553.33M |
| Financing Cash Flow | 0.00 | -2.40B | 98.78M | -3.28B | 906.74M | -2.28B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥14.79B | 14.72 | ― | 2.18% | 8.87% | 31.93% | |
75 Outperform | ¥14.42B | 12.16 | ― | 3.02% | 3.43% | 3.75% | |
70 Outperform | ¥10.87B | 8.70 | ― | 2.23% | ― | ― | |
70 Outperform | ¥17.12B | 9.82 | ― | 1.66% | 12.23% | 65.42% | |
68 Neutral | ¥5.99B | 33.95 | ― | 2.90% | -0.14% | -32.62% | |
65 Neutral | ¥15.75B | 173.69 | ― | 4.42% | -11.74% | -84.61% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |